Planned website maintenance is taking place from 11:00 pm AEDT on Friday 30 October to 6:00 am AEDT on Saturday 31 October 2026. Some pages may be temporarily unavailable. If issues continue outside this time, please contact us.
Notice for palopegteriparatide (Specialised Therapeutics Pharma Pty Ltd)
Active ingredients
palopegteriparatide
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
solution for injection in pre-filled pen
Indication
Treatment of hypoparathyroidism
Therapeutic area
Endocrinology